MaxCyte Signs Strategic Platform License with LG Chem to Advance its Allogeneic CAR-T Programs

Author's Avatar
Jul 12, 2022

LG Chem to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to accelerate the development of its T-cell therapy candidates for solid tumors